Request an Appointment or 214-645-8300

MedBlog

All Cancer

Cancer

Sex after prostate cancer: Treatment choice matters

Men with prostate cancer and their partners often are reluctant to talk about sexual health after treatment, but it’s a natural concern. Learn about a treatment called SAbR that can preserve sexual potency and about a clinical trial that we hope will make it even safer.

Cancer

4 Common Cancer-Screening Myths Busted

When it comes to cancer, prevention and early detection are often the best medicine, but confusion and misinformation about screenings continue to run rampant. We’re setting the record straight for patients and their families.

Cancer

Cancer Clinical Trials 101

If you’ve been diagnosed with cancer and are considering a clinical trial, you no doubt have questions. We have answers.

Cancer

Not a cure, but an extension: How immunotherapy works for advanced lung cancer

Data released in April 2018 suggest that adding immunotherapy to chemotherapy can extend the lives of some advanced lung cancer patients. Discover how immunotherapy works and who might benefit.

Cancer

Closer to a cure

A new clinical trial at UT Southwestern aims to offer new hope for patients with multiple myeloma.

Cancer

The Fight Continues

When 72-year-old Larry Carlson was diagnosed with stage 4 kidney cancer, he simply didn’t believe the news. Initially, Mr. Carlson was in denial about his cancer, but once he accepted the diagnosis, he decided that giving up wasn’t going to be a part of his plan.

Cancer

Prostate cancer genomic testing is flawed: Three reasons why

Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated recommendations, but it’s far from perfect. Claus Roehrborn, M.D., explains why genomic testing isn’t a “crystal ball” for predicting prostate cancer risk.

Cancer

Ovarian cancer: A step closer to demystifying early detection and prevention

Confirmed: Ovarian cancer begins in the fallopian tubes, not the ovaries. Discover how new research might be the key to overcoming barriers to early detection and prevention.

Cancer

Beat AML: Promising outcomes for seniors with acute myeloid leukemia

Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.

Cancer

Perspectives 75: Misti

After finding a lump in her breast, Misti was dignosed with stage 2 invasive ductal carcinoma with lobular features.